Identification of mechanisms driving acquired chemoresistance in preclinical breast cancer models of taxane resistance

被引：0
|
作者：
Taylor, Karen J. [1 ]
Lyttle, Nicola [2 ]
Lao, Linda [2 ]
Gourley, Charlie [1 ]
Cameron, David A. [1 ]
Bartlett, John M. S. [2 ]
Spears, Melanie [2 ]
机构：
[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[2] Ontario Inst Canc Res, Toronto, ON, Canada
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P6-03-21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-03-21
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Identification of chemoresistance-associated miRNAs in breast cancer
    Lou, Weiyang
    Liu, Jingxing
    Ding, Bisha
    Xu, Liang
    Fan, Weimin
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4747 - 4757
  • [32] Novel mechanisms of taxane and platinum resistance in Oesophagogastric Cancer Cells
    Matula, K. M.
    Collie-Duguid, E.
    Petty, R. D.
    EJC SUPPLEMENTS, 2010, 8 (07): : 199 - 199
  • [33] Acquired endocrine resistance in breast cancer
    Nature Reviews Endocrinology, 2014, 10 (2) : 66 - 66
  • [34] Identification of Inhibitors with Specificity for Breast Cancer Cells with Acquired Resistance to Endocrine Treatment
    Aguilar, H.
    Halonen, P.
    Serra-Musach, J.
    Rodriguez-Vida, A.
    Tirado, O. M.
    Beijersbergen, R. L.
    Urruticoechea, A.
    Pujana, M. A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 53 - 53
  • [35] Deconvoluting dynamics of acquired chemoresistance in Triple Negative Breast Cancer tumors
    Kumar, Pooja
    Menghi, Francesca
    Straub, Robert
    Mukashyaka, Patience
    Lloyd, Michael W.
    Chandok, Harshpreet
    George, Joshy
    Chuang, Jeffery
    Liu, Edison
    CANCER RESEARCH, 2023, 83 (05)
  • [36] BREAST CANCER PRECLINICAL MODELS: A VITAL RESOURCE FOR COMPREHENDING DISEASE MECHANISMS AND THERAPEUTIC DEVELOPMENT
    Kaur, Ravneet
    Sharma, Anuradha
    Wijekoon, Nalaka
    EXCLI JOURNAL, 2025, 24 : 267 - 285
  • [37] Identification and Therapeutic Inhibition of Pathways Driving Resistance to Targeted Breast Cancer Therapies
    Wood, Kris C.
    Anderson, Grace R.
    Wardell, Suzanne E.
    Jasper, Jeff S.
    Stein, Elizabeth M.
    Martz, Colin A.
    Alley, Holly M.
    Haney, Victoria
    Yllanes, Alexander
    Blackwell, Kimberly L.
    McCall, Shannon J.
    McDonnell, Donald P.
    JOURNAL OF WOMENS HEALTH, 2016, 25 (09) : 976 - 976
  • [38] Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer
    Ponnusamy, Logeswari
    Mahalingaiah, Prathap Kumar S.
    Chang, Yu-Wei
    Singh, Kamaleshwar P.
    CANCER DRUG RESISTANCE, 2019, 2 (02) : 297 - 312
  • [39] The cardio-oncologic burden of breast cancer: molecular mechanisms and importance of preclinical models
    Brauer, J.
    Tumani, M.
    Frey, N.
    Lehmann, L. H.
    BASIC RESEARCH IN CARDIOLOGY, 2025, 120 (01) : 91 - 112
  • [40] Mechanisms of resistance toward the FGFR inhibitor rogaratinib in preclinical urothelial bladder cancer models
    Jerchel, Isabel S.
    Kamburov, Atanas
    Zitzmann-Kolbe, Sabine
    Lesche, Ralf
    Walter, Alexander
    Mumberg, Dominik
    Politz, Oliver
    Gruenewald, Sylvia
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
12345